Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGF-β
Yingzheng Xu, Michael T. Patterson, Bastien Dolfi, Alisha Zhu, Adeline Bertola, Patricia R. Schrank, Alexandre Gallerand, Ainsley E. Kennedy, Hannah Hillman, Lynn Dinh, Sia Shekhar, Samuel Tollison, Tyler D. Bold, Stoyan Ivanov, Jesse W. Williams
Yingzheng Xu, Michael T. Patterson, Bastien Dolfi, Alisha Zhu, Adeline Bertola, Patricia R. Schrank, Alexandre Gallerand, Ainsley E. Kennedy, Hannah Hillman, Lynn Dinh, Sia Shekhar, Samuel Tollison, Tyler D. Bold, Stoyan Ivanov, Jesse W. Williams
View: Text | PDF
Research Article Endocrinology Immunology

Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGF-β

  • Text
  • PDF
Abstract

Glucocorticoid synthesis by adrenal glands (AGs) is regulated by the hypothalamic-pituitary-adrenal axis to facilitate stress responses when the host is exposed to stimuli. Recent studies implicate macrophages as potential steroidogenic regulators, but the molecular mechanisms by which AG macrophages exert such influence remain unclear. In this study, we investigated the role of AG macrophages in response to cold challenge or atherosclerotic inflammation as physiologic models of acute or chronic stress. Using single-cell RNA sequencing, we observed dynamic AG macrophage polarization toward classical activation and lipid-associated phenotypes following acute or chronic stimulation. Among transcriptional alterations induced in macrophages, triggering receptor expressed on myeloid cells 2 (Trem2) was highlighted because of its upregulation following stress. Conditional deletion of macrophage Trem2 revealed a protective role in stress responses. Mechanistically, Trem2 deletion led to increased AG macrophage death, abolished the TGF-β–producing capacity of AG macrophages, and resulted in enhanced glucocorticoid production. In addition, enhanced glucocorticoid production was replicated by blockade of TGF-β signaling. Together, these observations suggest that AG macrophages restrict steroidogenesis through Trem2 and TGF-β, which opens potential avenues for immunotherapeutic interventions to resolve stress-related disorders.

Authors

Yingzheng Xu, Michael T. Patterson, Bastien Dolfi, Alisha Zhu, Adeline Bertola, Patricia R. Schrank, Alexandre Gallerand, Ainsley E. Kennedy, Hannah Hillman, Lynn Dinh, Sia Shekhar, Samuel Tollison, Tyler D. Bold, Stoyan Ivanov, Jesse W. Williams

×

Figure 6

Trem2 modulates steroidogenesis through TGF-β.

Options: View larger image (or click on image) Download as PowerPoint
Trem2 modulates steroidogenesis through TGF-β.
(A) Linear correlation an...
(A) Linear correlation analysis showing Trem2- and Star-associated features in control AG macrophages; each dot represents a gene. (B) P values of highlighted genes in A. (C) Whole AG RNA-Seq: heatmap showing Trem2, TGF-β, LTBP family, and Star in control or Trem2-deficient (CX3CR1creER Trem2fl Ldlr–/–) atherosclerotic mice. Control, n = 5; Trem2-deficient, n = 4. (D) Enrichment plot showing steroid hormone biosynthesis GSEA pathways comparing WT against Trem2-deficient atherosclerotic mouse AGs. (E) Enrichment plot showing TGF-β signaling pathways comparing WT against CX3CR1creER Trem2fl Ldlr–/– atherosclerotic mice. (F) Percentage of LAP+ WT or Trem2–/– BV2 at baseline. WT BV2, n = 5;Trem2–/– BV2, n = 5 replicates. Significance determined by Student’s t test, ****P < 0.0001. (G) Histogram showing LAP MFI. FMO, fluorescence minus one. (H) Percentage of LAP+ BV2 cells, cocultured with Y1. WT BV2, n = 6 replicates. Trem2–/– BV2, n = 6 replicates. Significance determined by Student’s t test, **P < 0.005. (I) Percentage of LAP+ BV2 cells, cocultured with Y1, with ACTH. WT BV2, n = 6 replicates. Trem2–/– BV2, n = 6 replicates. Significance determined by Student’s t test, **P < 0.005. (J) Concentration of TGF-β in cell culture supernatant. WT (red), n = 6. Trem2–/– (green), ACTH+, n = 5, ACTH–, n = 6. Significance determined by Student’s t test, **P < 0.005. (K) Immunofluorescence staining of LTBP4, CD68, and DAPI in CX3CR1creER Trem2WT Ldlr–/– or CX3CR1creER Trem2fl Ldlr–/– mice fed TAM-HFD for 12 weeks. (L) Quantification of LTBP4 by MFI of red pixels, n = 6 for each group. Significance determined by Student’s t test, ***P < 0.001. (M) Serum TGF-β in CX3CR1creER Trem2WT Ldlr–/– (Trem2WT♂ n = 3, or Trem2WT ♀ n = 4) or CX3CR1creER Trem2fl Ldlr–/– (MΦTrem2Δ♂ n = 4, or MΦTrem2Δ♀ n = 6) mice after 16 weeks of TAM-HFD. Significance determined by ANOVA, *P < 0.05, **P < 0.005. Panels F, H, I, J, L, and M are presented as mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts